drugset / Trial / NCT00855439

Evaluation of Exenatide in Patients With Diabetic Neuropathy

NCT00855439

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will look at whether or not the medication exenatide improves signs and symptoms of diabetic peripheral neuropathy in people with type 2 diabetes and mild to moderate diabetic peripheral neuropathy.

Timeline

Start
2008-06
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide Subcutaneous
Comparator insulin glargine Protein / enzyme biologic